MAP3K7 and autoimmune pancreatitis: In the latter two models, an inhibitor of MAP3K7/TAK1, 5Z‐7‐oxozeaenol (OZ), attenuated progression of the disease and will therefore be of interest in the context of experimental AIP as well.